zoledronic acid has been researched along with Injuries, Spinal Cord in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharjee, R; Singhania, P | 1 |
| Barroso, J; Edwards, WB; Haider, IT; Schnitzer, TJ; Simonian, N | 2 |
| Barroso, J; Crack, LE; Edwards, WB; Gabel, L; Haider, IT; Schnitzer, TJ; Simonian, N | 1 |
| Formal, CS; Leiby, BE; Marino, RJ; Modlesky, CM; Oleson, CV | 1 |
| Battaglino, RA; Fang, Y; Goldstein, RF; Morse, LR; Nguyen, N; Troy, KL | 1 |
| Goenka, S; Jindal, R; Joshi, M; Pandey, N; Sethi, S | 1 |
| Beaupre, GS | 1 |
| Bauman, WA; Cirnigliaro, CM; Kirshblum, SC; La Fountaine, MF; Martinez, L; Spungen, AM | 1 |
| Chen, D; Kim, K; Marks, J; Schnitzer, TJ; Simonian, N; Yeasted, R | 1 |
| Bubbear, JS; Ferguson-Pell, M; Gall, A; Keen, RW; Middleton, FR; Swaminathan, R | 1 |
| Briody, J; McQuade, M; Munns, CF; Ooi, HL | 1 |
| Ballard, P; Beck, T; BrintzenhofeSzoc, K; Caminis, J; Dapthary, M; Shapiro, J; Smith, B | 1 |
7 trial(s) available for zoledronic acid and Injuries, Spinal Cord
| Article | Year |
|---|---|
Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Femur; Femur Neck; Humans; Spinal Cord Injuries; Walking; Zoledronic Acid | 2023 |
The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.
Topics: Acute Disease; Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Double-Blind Method; Female; Femur; Humans; Male; Middle Aged; Pelvic Bones; Spinal Cord Injuries; Young Adult; Zoledronic Acid | 2020 |
Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: a randomized, controlled trial.
Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Spinal Cord Injuries; Time-to-Treatment; Zoledronic Acid | 2021 |
Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Femur; Hip; Humans; Male; Spinal Cord Injuries; Time Factors; Treatment Outcome; Zoledronic Acid | 2018 |
Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results of a Randomized, Placebo-Controlled Pilot Trial.
Topics: Bone Density; Diphosphonates; Double-Blind Method; Humans; Imidazoles; Pilot Projects; Spinal Cord Injuries; Zoledronic Acid | 2016 |
Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
Topics: Adolescent; Adult; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Drug Administration Schedule; Female; Follow-Up Studies; Hip Joint; Humans; Imidazoles; Lumbar Vertebrae; Male; Osteoporosis; Spinal Cord Injuries; Young Adult; Zoledronic Acid | 2011 |
Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
Topics: Adolescent; Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Femur; Femur Neck; Humans; Imidazoles; Male; Spinal Cord Injuries; Zoledronic Acid | 2007 |
6 other study(ies) available for zoledronic acid and Injuries, Spinal Cord
| Article | Year |
|---|---|
Letter to the Editor Regarding "Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss After Spinal Cord Injury: A Randomized, Controlled Trial".
Topics: Bone Diseases, Metabolic; Diphosphonates; Humans; Spinal Cord Injuries; Time-to-Treatment; Zoledronic Acid | 2022 |
Reply to Letter to the Editor Regarding "Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss After Spinal Cord Injury: A Randomized, Controlled Trial".
Topics: Bone Diseases, Metabolic; Diphosphonates; Humans; Spinal Cord Injuries; Time-to-Treatment; Zoledronic Acid | 2022 |
Functional electrical stimulation (FES)-assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury.
Topics: Adult; Bone Density; Electric Stimulation; Femur; Humans; Spinal Cord Injuries; Water Sports; Zoledronic Acid | 2021 |
Correspondence: "Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial".
Topics: Bone Density; Humans; Imidazoles; Spinal Cord Injuries; Zoledronic Acid | 2018 |
Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Female; Femur; Humans; Imidazoles; Knee; Male; Middle Aged; Prospective Studies; Spinal Cord Injuries; Tibia; Young Adult; Zoledronic Acid | 2015 |
Zoledronic acid improves bone mineral density in pediatric spinal cord injury.
Topics: Bone and Bones; Bone Density; Child; Densitometry; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Myelitis, Transverse; Osteoporosis; Spinal Cord Injuries; Tibia; Treatment Outcome; Zoledronic Acid | 2012 |